On Jun. 15, 2022, Roche announced that the US Food and Drug Administration had issued Emergency Use Authorization…
On Jun. 14 2022, Pfizer reported data from the Phase 2/3 EPIC-SR (Evaluation of Protease Inhibition for COVID-19…
On Jun. 13 2022, Novavax announced that the Australian Therapeutic Goods Administration (TGA) has granted provisional registration of…
On Jun. 8, 2022, Moderna announced new clinical data on its Omicron-containing bivalent COVID booster candidate, mRNA-1273.214, containing…
On Jun. 7, 2022, Merck and Ridgeback Biotherapeutics announced the Annals of Internal Medicine had published additional data…
On Jun. 7, 2022, Veru announced that is had submitted an emergency use authorization (EUA) application to the…
On Jun. 6, 2022, Pfizer further strengthened its commitment to United States manufacturing with a $120 million investment…
On Jun. 4, 2022, researchers reported that in areas with large cattle populations and a high prevalence of…
On Jun. 2, 2022, Moderna announced an agreement with the European Commission (EC) to amend their originally agreed…
On Jun. 2, 2022, Novavax announced the submission of a request to the Medicines and Healthcare products Regulatory…
On Jun. 2, 2022, the U.S. National Institutes of Health announced that a large randomized, placebo-controlled clinical trial…
On Jun. 1, 2022, the U.S. National Institutes of Health announced that an NIH funded study had found…
On May 31, 2022, Moderna and Takeda announced the transfer of the marketing authorization for Moderna’s COVID-19 vaccine…
On May 25, 2022, Pfizer and BioNTech announced topline safety, immunogenicity and vaccine efficacy data from a Phase…
On May 25, 2022, Novavax announced it was participating in a stage of the COVID-19 Vaccine Schedule Combinations…
On May 24, 2022, scientists at the Broad Institute of MIT and Harvard and the University of Massachusetts…
On May 20, 2022, Novavax announced the submission of a request to the European Medicines Agency to expand…
On May 19, 2022, the U.S. National Institutes of Health (NIH) announced that people who reported in a…
On May 19, 2022, WHO issued an emergency use listing (EUL) for CONVIDECIA, a vaccine manufactured by CanSino…
On May 18, 2022, the U.S. National Institutes of Health announced it had awarded approximately $577 million to…
On May 18, 2022, LabCorp announced the receipt of Emergency Use Authorization (EUA) from the U.S. Food and…
On May 17, 2022, OraSure Technologies announced that its InteliSwabï¾® COVID-19 rapid tests detect the Omicron BA.2, BA.2.12.1,…
On May 17, 2022, Pfizer and BioNTech announced the U.S. Food and Drug Administration expanded emergency use authorization…
On May 16, 2022, working with state and federal wildlife agencies and private and public zoos across Arizona,…
On May 13, 2022, Novavax announced the submission of a request for emergency use authorization to Taiwanï¾’s Food…
On May 12, 2022, WHOï¾’s COVID-19 Technology Access Pool and the Medicines Patent Pool finalized a licensing agreement…
On May 12, 2022, Cepheid announced it had received Emergency Use Authorization from the U.S. Food & Drug…
On May 12, 2022, the U.S. National Institutes of Health announced that it had licensed 11 COVID-19 research…
On May 11, 2022, Lucira Health announced that it had submitted a request to the U.S. Food and…
On May 11, 2022, Kaiser Permanente Washington Health Research Institute reported that new treatments for people at high…